About a quarter of Americans have used emerging cannabinoids — such as cannabidiol (CBD), cannabigerol (CBG), and cannabinol (CBN) — in the past year, according to a cross-sectional survey. Among 1,169 participants who completed the poll, 25.2% reported past-year use of these compounds,, Kevin Boehnke, PhD, of the University of Michigan Medical School in Ann Arbor, and colleagues reported in a JAMA Network Open research letter.  Read the article here.